Tarsus Pharmaceuticals
The VP, Market Access at Tarsus reports to the Chief Commercial Officer and is responsible for shaping and executing the company's market access strategy to expand patient access and drive commercial growth. This enterprise leader will oversee payer strategy, pricing, contracting, reimbursement, and patient services while building the access infrastructure for future products. The role involves leading high-performing teams, embedding access considerations early in product development, and partnering across the organization to translate strategy into measurable results.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
VP of Access Strategy & Payer Engagement
Ocular Therapeutix
Vice President, Market Access
Mirum Pharmaceuticals
Head of Market Access, US
Orion
Head of Market Access, US
oraclecloudinfrastructure
VP Market Access & Pricing
MoonLake Immunotherapeutics
Senior Director, Market Access Pricing & Contracting
NewAmsterdam Pharma